| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69238-2027-2 | 69238-2027 | HUMAN PRESCRIPTION DRUG | Spironolactone | Spironolactone | SUSPENSION | ORAL | 20230908 | N/A | ANDA | ANDA215572 | Amneal Pharmaceuticals NY LLC | SPIRONOLACTONE | 25 mg/5mL | 473 mL in 1 BOTTLE (69238-2027-2) |
| 69238-2027-8 | 69238-2027 | HUMAN PRESCRIPTION DRUG | Spironolactone | Spironolactone | SUSPENSION | ORAL | 20230908 | N/A | ANDA | ANDA215572 | Amneal Pharmaceuticals NY LLC | SPIRONOLACTONE | 25 mg/5mL | 118 mL in 1 BOTTLE (69238-2027-8) |
| 17856-2028-3 | 17856-2028 | HUMAN PRESCRIPTION DRUG | Spironolactone | Spironolactone | SUSPENSION | ORAL | 20240416 | N/A | ANDA | ANDA215572 | ATLANTIC BIOLOGICALS CORP. | SPIRONOLACTONE | 25 mg/5mL | 60 SYRINGE in 1 PACKAGE (17856-2028-3) / 10 SYRINGE in 1 SYRINGE (17856-2028-2) / 2.5 mL in 1 SYRINGE (17856-2028-1) |